speb/financial-data huggingface dataset:
FGNXP balance_sheet (annual, 2022-12-31) — Tangible Book Value: 14930000.00
FGNXP income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
FGNXP income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.21
FGNXP balance_sheet (annual, 2022-12-31) — Total Assets: 49475000.00
FGNXP balance_sheet (annual, 2022-12-31) — Total Capitalization: 37295000.00
FGNXP balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 37295000.00
FGNXP income_statement (annual, 2022-12-31) — Total Expenses: 11389000.00
FGNXP balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 12180000.00
FGNXP balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 0.00
FGNXP cash_flow (annual, 2022-12-31) — Unrealized Gain Loss On Investment Securities: -13026000.00
FGNXP income_statement (annual, 2023-12-31) — +Operating Expense: 11908000.00
FGNXP income_statement (annual, 2023-12-31) — +Total Revenue: 17093000.00
FGNXP balance_sheet (annual, 2023-12-31) — Accounts Payable: 4834000.00
FGNXP balance_sheet (annual, 2023-12-31) — Accounts Receivable: 3529000.00
FGNXP balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -1751000.00
FGNXP balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 55856000.00
FGNXP cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 0.00
FGNXP balance_sheet (annual, 2023-12-31) — Assets Held For Sale Current: 9886000.00
FGNXP cash_flow (annual, 2023-12-31) — Beginning Cash Position: 3063000.00
FGNXP balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 9469000.00
FGNXP cash_flow (annual, 2023-12-31) — Capital Expenditure: -164000.00
FGNXP cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -164000.00
FGNXP balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 1704000.00
FGNXP balance_sheet (annual, 2023-12-31) — Capital Stock: 225000.00
FGNXP balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 5995000.00
FGNXP balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 16547000.00
FGNXP cash_flow (annual, 2023-12-31) — Cash Dividends Paid: 0.00
FGNXP cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 1240000.00
FGNXP cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: 92000.00
FGNXP cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 1579000.00
FGNXP cash_flow (annual, 2023-12-31) — Cash Flow From Discontinued Operation: 67000.00
FGNXP cash_flow (annual, 2023-12-31) — Cash From Discontinued Financing Activities: 2143000.00
FGNXP cash_flow (annual, 2023-12-31) — Cash From Discontinued Investing Activities: -787000.00
FGNXP cash_flow (annual, 2023-12-31) — Cash From Discontinued Operating Activities: -1423000.00
FGNXP cash_flow (annual, 2023-12-31) — Change In Account Payable: -196000.00
FGNXP cash_flow (annual, 2023-12-31) — Change In Inventory: 393000.00
FGNXP cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 378000.00
FGNXP cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -151000.00
FGNXP cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -444000.00
FGNXP cash_flow (annual, 2023-12-31) — Change In Payable: -196000.00
FGNXP cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 817000.00
FGNXP cash_flow (annual, 2023-12-31) — Change In Receivables: 1831000.00
FGNXP cash_flow (annual, 2023-12-31) — Change In Working Capital: 2824000.00
FGNXP cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 1831000.00
FGNXP cash_flow (annual, 2023-12-31) — Changes In Cash: 2911000.00
FGNXP balance_sheet (annual, 2023-12-31) — Common Stock: 225000.00
FGNXP balance_sheet (annual, 2023-12-31) — Common Stock Equity: 35149000.00
FGNXP cash_flow (annual, 2023-12-31) — Common Stock Issuance: 2411000.00
FGNXP income_statement (annual, 2023-12-31) — Cost Of Revenue: 21476000.00
FGNXP balance_sheet (annual, 2023-12-31) — Current Assets: 31444000.00
FGNXP balance_sheet (annual, 2023-12-31) — Current Debt: 2294000.00
FGNXP balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 2294000.00
FGNXP balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 867000.00
FGNXP balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 867000.00
FGNXP balance_sheet (annual, 2023-12-31) — Current Deferred Taxes Liabilities: 3075000.00
FGNXP balance_sheet (annual, 2023-12-31) — Current Liabilities: 14794000.00
FGNXP cash_flow (annual, 2023-12-31) — Deferred Income Tax: -933000.00
FGNXP cash_flow (annual, 2023-12-31) — Deferred Tax: -933000.00
FGNXP cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 841000.00
FGNXP cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 841000.00
FGNXP income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -14077000.00
FGNXP cash_flow (annual, 2023-12-31) — Dividends Received Cfi: 764000.00
FGNXP income_statement (annual, 2023-12-31) — EBIT: -12785000.00
FGNXP income_statement (annual, 2023-12-31) — EBITDA: -11944000.00
FGNXP cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: 9437000.00
FGNXP cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 21000.00
FGNXP cash_flow (annual, 2023-12-31) — End Cash Position: 5995000.00
FGNXP cash_flow (annual, 2023-12-31) — Financing Cash Flow: 1240000.00
FGNXP balance_sheet (annual, 2023-12-31) — Finished Goods: 1476000.00
FGNXP cash_flow (annual, 2023-12-31) — Free Cash Flow: 1415000.00
FGNXP cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 2000.00
FGNXP cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of Business: -1000.00
FGNXP income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -1000.00
FGNXP balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -4682000.00
FGNXP income_statement (annual, 2023-12-31) — General And Administrative Expense: 11111000.00
FGNXP balance_sheet (annual, 2023-12-31) — Gross PPE: 14495000.00
FGNXP income_statement (annual, 2023-12-31) — Gross Profit: -4383000.00
FGNXP income_statement (annual, 2023-12-31) — Interest Expense: 520000.00
FGNXP income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 520000.00
FGNXP balance_sheet (annual, 2023-12-31) — Inventory: 1482000.00
FGNXP balance_sheet (annual, 2023-12-31) — Invested Capital: 42904000.00
FGNXP cash_flow (annual, 2023-12-31) — Investing Cash Flow: 92000.00
FGNXP balance_sheet (annual, 2023-12-31) — Investments And Advances: 17469000.00
FGNXP cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 2411000.00
FGNXP cash_flow (annual, 2023-12-31) — Issuance Of Debt: 0.00
FGNXP balance_sheet (annual, 2023-12-31) — Land And Improvements: 2342000.00
FGNXP balance_sheet (annual, 2023-12-31) — Line Of Credit: 0.00
FGNXP balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 1704000.00
FGNXP balance_sheet (annual, 2023-12-31) — Long Term Debt: 5461000.00
FGNXP balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 7165000.00
FGNXP cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 0.00
FGNXP cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -383000.00
FGNXP balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 17469000.00
FGNXP income_statement (annual, 2023-12-31) — Loss Adjustment Expense: 9713000.00
FGNXP balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 1055000.00
FGNXP balance_sheet (annual, 2023-12-31) — Minority Interest: 1858000.00
FGNXP income_statement (annual, 2023-12-31) — Minority Interests: 564000.00
FGNXP cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 58000.00
FGNXP cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 2411000.00
FGNXP balance_sheet (annual, 2023-12-31) — Net Debt: 1760000.00
FGNXP income_statement (annual, 2023-12-31) — Net Income: -14077000.00
FGNXP income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -14077000.00
FGNXP income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -12307000.00
FGNXP income_statement (annual, 2023-12-31) — Net Income Discontinuous Operations: -2334000.00
FGNXP income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -14077000.00
FGNXP income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -11743000.00
FGNXP cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -12307000.00
FGNXP income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -14641000.00
FGNXP income_statement (annual, 2023-12-31) — Net Interest Income: -520000.00
FGNXP cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 198000.00
FGNXP cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -1036000.00
FGNXP cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -383000.00
FGNXP income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -520000.00
FGNXP cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -135000.00
FGNXP balance_sheet (annual, 2023-12-31) — Net PPE: 12744000.00
FGNXP cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: 0.00
FGNXP income_statement (annual, 2023-12-31) — Net Policyholder Benefits And Claims: 9713000.00
FGNXP cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: -653000.00
FGNXP balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 35149000.00
FGNXP balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 3075000.00
FGNXP balance_sheet (annual, 2023-12-31) — Non Current Deferred Revenue: 867000.00
FGNXP balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 3075000.00
FGNXP income_statement (annual, 2023-12-31) — Normalized EBITDA: -15450000.00
FGNXP income_statement (annual, 2023-12-31) — Normalized Income: -14986017.06
FGNXP cash_flow (annual, 2023-12-31) — Operating Cash Flow: 1579000.00
FGNXP cash_flow (annual, 2023-12-31) — Operating Gains Losses: 9438000.00
FGNXP income_statement (annual, 2023-12-31) — Operating Income: -16291000.00
FGNXP income_statement (annual, 2023-12-31) — Operating Revenue: 17093000.00
FGNXP balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 84471.00
FGNXP balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 2294000.00
FGNXP balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 6799000.00
FGNXP balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -4682000.00
FGNXP income_statement (annual, 2023-12-31) — Other Gand A: 11111000.00
FGNXP income_statement (annual, 2023-12-31) — Other Income Expense: 3506000.00
FGNXP cash_flow (annual, 2023-12-31) — Other Non Cash Items: 138000.00
FGNXP balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 486000.00
FGNXP balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 102000.00
FGNXP income_statement (annual, 2023-12-31) — Other Operating Expenses: 12583000.00
FGNXP balance_sheet (annual, 2023-12-31) — Other Properties: 1629000.00
FGNXP balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 10552000.00
FGNXP balance_sheet (annual, 2023-12-31) — Payables: 4834000.00
FGNXP balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 4834000.00
FGNXP balance_sheet (annual, 2023-12-31) — Preferred Shares Number: 894580.00
FGNXP balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
FGNXP cash_flow (annual, 2023-12-31) — Preferred Stock Dividend Paid: 0.00
FGNXP income_statement (annual, 2023-12-31) — Preferred Stock Dividends: 1786000.00
FGNXP balance_sheet (annual, 2023-12-31) — Preferred Stock Equity: 22365000.00
FGNXP income_statement (annual, 2023-12-31) — Pretax Income: -13305000.00
FGNXP balance_sheet (annual, 2023-12-31) — Properties: 0.00
FGNXP cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: -27000.00
FGNXP cash_flow (annual, 2023-12-31) — Purchase Of Business: -495000.00
FGNXP cash_flow (annual, 2023-12-31) — Purchase Of Investment: -950000.00
FGNXP cash_flow (annual, 2023-12-31) — Purchase Of PPE: 0.00
FGNXP balance_sheet (annual, 2023-12-31) — Raw Materials: 0.00
FGNXP balance_sheet (annual, 2023-12-31) — Receivables: 3529000.00
FGNXP income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 21476000.00
FGNXP income_statement (annual, 2023-12-31) — Reconciled Depreciation: 841000.00
FGNXP cash_flow (annual, 2023-12-31) — Repayment Of Debt: -1036000.00
FGNXP income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: -3502000.00
FGNXP balance_sheet (annual, 2023-12-31) — Retained Earnings: 2336000.00
FGNXP cash_flow (annual, 2023-12-31) — Sale Of Business: 58000.00
FGNXP cash_flow (annual, 2023-12-31) — Sale Of Investment: 198000.00
FGNXP cash_flow (annual, 2023-12-31) — Sale Of PPE: 0.00
FGNXP income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 797000.00
FGNXP income_statement (annual, 2023-12-31) — Selling General And Administration: 11908000.00
FGNXP balance_sheet (annual, 2023-12-31) — Share Issued: 84471.00
FGNXP cash_flow (annual, 2023-12-31) — Short Term Debt Payments: -653000.00
FGNXP income_statement (annual, 2023-12-31) — Special Income Charges: 3507000.00
FGNXP cash_flow (annual, 2023-12-31) — Stock Based Compensation: 1605000.00
FGNXP balance_sheet (annual, 2023-12-31) — Stockholders Equity: 35149000.00
FGNXP balance_sheet (annual, 2023-12-31) — Tangible Book Value: 35149000.00
FGNXP income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 262982.94
FGNXP income_statement (annual, 2023-12-31) — Tax Provision: -998000.00
FGNXP income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.08
FGNXP balance_sheet (annual, 2023-12-31) — Total Assets: 62143000.00
FGNXP balance_sheet (annual, 2023-12-31) — Total Capitalization: 40610000.00
FGNXP balance_sheet (annual, 2023-12-31) — Total Debt: 9459000.00
FGNXP balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 37007000.00
FGNXP income_statement (annual, 2023-12-31) — Total Expenses: 33384000.00
FGNXP balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 25136000.00
FGNXP balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 30699000.00
FGNXP balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 10342000.00
FGNXP income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -16286000.00
FGNXP income_statement (annual, 2023-12-31) — Total Unusual Items: 3506000.00
FGNXP income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 3506000.00
FGNXP balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
FGNXP balance_sheet (annual, 2023-12-31) — Treasury Stock: 18586000.00
FGNXP cash_flow (annual, 2023-12-31) — Unrealized Gain Loss On Investment Securities: -3059000.00
FGNXP balance_sheet (annual, 2023-12-31) — Work In Process: 6000.00
FGNXP balance_sheet (annual, 2023-12-31) — Working Capital: 16650000.00
FGNXP income_statement (annual, 2023-12-31) — Write Off: -5000.00
FGNXP income_statement (quarterly, 2024-09-30) — +Operating Expense: 2946000.00
FGNXP balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 24058000.00
FGNXP cash_flow (quarterly, 2024-09-30) — Capital Expenditure: -32000.00
FGNXP cash_flow (quarterly, 2024-09-30) — Capital Expenditure Reported: -32000.00
FGNXP balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 1324000.00
FGNXP cash_flow (quarterly, 2024-09-30) — Cash Flow From Discontinued Operation: 281000.00
FGNXP cash_flow (quarterly, 2024-09-30) — Change In Receivables: -403000.00
FGNXP cash_flow (quarterly, 2024-09-30) — Changes In Account Receivables: -403000.00
FGNXP cash_flow (quarterly, 2024-09-30) — Common Stock Issuance: 0.00
FGNXP income_statement (quarterly, 2024-09-30) — Earnings From Equity Interest: -2636000.00
FGNXP cash_flow (quarterly, 2024-09-30) — Gain Loss On Investment Securities: -432000.00
FGNXP income_statement (quarterly, 2024-09-30) — Interest Expense: 66000.00
FGNXP income_statement (quarterly, 2024-09-30) — Interest Expense Non Operating: 66000.00
FGNXP cash_flow (quarterly, 2024-09-30) — Issuance Of Capital Stock: 0.00
FGNXP balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 1324000.00
FGNXP balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 369000.00
FGNXP balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 1693000.00
FGNXP income_statement (quarterly, 2024-09-30) — Loss Adjustment Expense: 2927000.00
FGNXP balance_sheet (quarterly, 2024-09-30) — Minority Interest: 0.00
FGNXP cash_flow (quarterly, 2024-09-30) — Net Common Stock Issuance: 0.00
FGNXP cash_flow (quarterly, 2024-09-30) — Net PPE Purchase And Sale: 4872000.00
FGNXP income_statement (quarterly, 2024-09-30) — Net Policyholder Benefits And Claims: 2927000.00
FGNXP balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Revenue: 900000.00
FGNXP income_statement (quarterly, 2024-09-30) — Operating Income: -2836000.00
FGNXP income_statement (quarterly, 2024-09-30) — Other Operating Expenses: 4589000.00
FGNXP balance_sheet (quarterly, 2024-09-30) — Receivables: 24058000.00
FGNXP income_statement (quarterly, 2024-09-30) — Salaries And Wages: 440000.00
FGNXP cash_flow (quarterly, 2024-09-30) — Sale Of PPE: 4872000.00
FGNXP income_statement (quarterly, 2024-09-30) — Selling And Marketing Expense: 315000.00
FGNXP income_statement (quarterly, 2024-09-30) — Total Operating Income As Reported: -2836000.00
FGNXP income_statement (quarterly, 2024-09-30) — Total Other Finance Cost: 36000.00
FGNXP balance_sheet (quarterly, 2024-09-30) — Treasury Stock: 0.00
FGNXP income_statement (annual, 2024-12-31) — +Operating Expense: 11013000.00
FGNXP income_statement (annual, 2024-12-31) — +Total Revenue: 779000.00
FGNXP balance_sheet (annual, 2024-12-31) — Accounts Payable: 842000.00
FGNXP balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 842000.00
FGNXP balance_sheet (annual, 2024-12-31) — Accounts Receivable: 3384000.00
FGNXP balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 3384000.00
FGNXP balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -1514000.00
FGNXP balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -1514000.00
FGNXP balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 50924000.00
FGNXP cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 1422000.00
FGNXP cash_flow (quarterly, 2024-12-31) — Asset Impairment Charge: 0.00
FGNXP balance_sheet (annual, 2024-12-31) — Assets Held For Sale Current: 39824000.00
FGNXP balance_sheet (quarterly, 2024-12-31) — Assets Held For Sale Current: 39824000.00
FGNXP cash_flow (annual, 2024-12-31) — Beginning Cash Position: 4558000.00
FGNXP balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 3247000.00
FGNXP balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 3247000.00
FGNXP cash_flow (annual, 2024-12-31) — Capital Expenditure: -46000.00
FGNXP cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -46000.00
FGNXP cash_flow (quarterly, 2024-12-31) — Capital Expenditure Reported: 6000.00
FGNXP balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 1372000.00
FGNXP balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 1372000.00
FGNXP balance_sheet (annual, 2024-12-31) — Capital Stock: 22394000.00
FGNXP balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 6562000.00
FGNXP balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 12325000.00
FGNXP cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -1410000.00
FGNXP cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -6856000.00
FGNXP cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 13288000.00
FGNXP cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -3940000.00
FGNXP cash_flow (annual, 2024-12-31) — Cash Flow From Discontinued Operation: 234000.00
FGNXP cash_flow (quarterly, 2024-12-31) — Cash Flow From Discontinued Operation: -35000.00
FGNXP cash_flow (annual, 2024-12-31) — Cash From Discontinued Financing Activities: -2000.00
FGNXP cash_flow (annual, 2024-12-31) — Cash From Discontinued Investing Activities: -140000.00
FGNXP cash_flow (annual, 2024-12-31) — Cash From Discontinued Operating Activities: -299000.00
FGNXP cash_flow (annual, 2024-12-31) — Change In Inventory: -19000.00
FGNXP cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 1080000.00
FGNXP cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -23000.00
FGNXP cash_flow (quarterly, 2024-12-31) — Change In Other Current Liabilities: -50000.00
FGNXP cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 58000.00
FGNXP cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 3212000.00
FGNXP cash_flow (annual, 2024-12-31) — Change In Receivables: 178000.00
FGNXP cash_flow (quarterly, 2024-12-31) — Change In Receivables: 967000.00
FGNXP cash_flow (annual, 2024-12-31) — Change In Working Capital: 4327000.00
FGNXP cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 178000.00
FGNXP cash_flow (quarterly, 2024-12-31) — Changes In Account Receivables: 967000.00
FGNXP cash_flow (annual, 2024-12-31) — Changes In Cash: 2051000.00
FGNXP balance_sheet (annual, 2024-12-31) — Common Stock: 29000.00
FGNXP balance_sheet (annual, 2024-12-31) — Common Stock Equity: 51832000.00
FGNXP cash_flow (annual, 2024-12-31) — Common Stock Issuance: 0.00
FGNXP cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 0.00
FGNXP cash_flow (annual, 2024-12-31) — Common Stock Payments: 0.00
FGNXP income_statement (annual, 2024-12-31) — Cost Of Revenue: 25493000.00
FGNXP balance_sheet (annual, 2024-12-31) — Current Assets: 52149000.00
FGNXP balance_sheet (quarterly, 2024-12-31) — Current Assets: 52149000.00
FGNXP balance_sheet (annual, 2024-12-31) — Current Debt: 2068000.00
FGNXP balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 2068000.00
FGNXP balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 857000.00
FGNXP balance_sheet (quarterly, 2024-12-31) — Current Deferred Liabilities: 857000.00
FGNXP balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 857000.00
FGNXP balance_sheet (quarterly, 2024-12-31) — Current Deferred Revenue: 857000.00
FGNXP balance_sheet (annual, 2024-12-31) — Current Deferred Taxes Liabilities: 2412000.00
FGNXP balance_sheet (quarterly, 2024-12-31) — Current Deferred Taxes Liabilities: 2412000.00
FGNXP balance_sheet (annual, 2024-12-31) — Current Liabilities: 32632000.00
FGNXP balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 32632000.00
FGNXP cash_flow (annual, 2024-12-31) — Deferred Income Tax: -639000.00
FGNXP cash_flow (annual, 2024-12-31) — Deferred Tax: -639000.00
FGNXP cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 408000.00
FGNXP cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 408000.00
FGNXP income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -2565000.00
FGNXP income_statement (annual, 2024-12-31) — EBIT: -24066000.00
FGNXP income_statement (annual, 2024-12-31) — EBITDA: -23658000.00
FGNXP income_statement (annual, 2024-12-31) — Earnings From Equity Interest: -14675000.00
FGNXP cash_flow (annual, 2024-12-31) — Earnings Losses From Equity Investments: 15752000.00
FGNXP cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -47000.00
FGNXP cash_flow (annual, 2024-12-31) — End Cash Position: 6562000.00
FGNXP cash_flow (annual, 2024-12-31) — Financing Cash Flow: -6858000.00
FGNXP balance_sheet (annual, 2024-12-31) — Finished Goods: 1432000.00
FGNXP balance_sheet (quarterly, 2024-12-31) — Finished Goods: 1432000.00
FGNXP cash_flow (annual, 2024-12-31) — Free Cash Flow: -4239000.00
FGNXP cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of Business: -306000.00
FGNXP cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
FGNXP income_statement (annual, 2024-12-31) — Gain On Sale Of Ppe: 0.00
FGNXP income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -2000.00
FGNXP balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 1108000.00
FGNXP income_statement (annual, 2024-12-31) — General And Administrative Expense: 11013000.00
FGNXP balance_sheet (annual, 2024-12-31) — Gross PPE: 5601000.00
FGNXP balance_sheet (quarterly, 2024-12-31) — Gross PPE: 5601000.00
FGNXP income_statement (annual, 2024-12-31) — Gross Profit: -8145000.00
FGNXP income_statement (annual, 2024-12-31) — Interest Expense: 303000.00
FGNXP income_statement (quarterly, 2024-12-31) — Interest Expense: 60000.00
FGNXP income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 303000.00
FGNXP income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 60000.00
FGNXP balance_sheet (annual, 2024-12-31) — Inventory: 1432000.00
FGNXP balance_sheet (quarterly, 2024-12-31) — Inventory: 1432000.00
FGNXP balance_sheet (annual, 2024-12-31) — Invested Capital: 53900000.00
FGNXP cash_flow (annual, 2024-12-31) — Investing Cash Flow: 13148000.00
FGNXP balance_sheet (annual, 2024-12-31) — Investments And Advances: 54310000.00
FGNXP balance_sheet (quarterly, 2024-12-31) — Investments And Advances: 54310000.00
FGNXP cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 0.00
FGNXP cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 0.00
FGNXP cash_flow (annual, 2024-12-31) — Issuance Of Debt: 97000.00
FGNXP cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 58000.00
FGNXP balance_sheet (annual, 2024-12-31) — Land And Improvements: 45000.00
FGNXP balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 45000.00
FGNXP balance_sheet (annual, 2024-12-31) — Line Of Credit: 0.00
FGNXP balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 1372000.00
FGNXP balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 1372000.00
FGNXP balance_sheet (annual, 2024-12-31) — Long Term Debt: 301000.00
FGNXP balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 301000.00
FGNXP balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 1673000.00
FGNXP balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 1673000.00
FGNXP cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 97000.00
FGNXP cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 58000.00
FGNXP cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -4919000.00
FGNXP cash_flow (quarterly, 2024-12-31) — Long Term Debt Payments: -137000.00
FGNXP balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 54310000.00
FGNXP balance_sheet (quarterly, 2024-12-31) — Long Term Equity Investment: 54310000.00
FGNXP balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 1003000.00
FGNXP balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 1003000.00
FGNXP balance_sheet (annual, 2024-12-31) — Minority Interest: 0.00
FGNXP balance_sheet (quarterly, 2024-12-31) — Minority Interest: 0.00
FGNXP income_statement (annual, 2024-12-31) — Minority Interests: 160000.00
FGNXP income_statement (quarterly, 2024-12-31) — Minority Interests: 0.00
FGNXP cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 1903000.00
FGNXP cash_flow (quarterly, 2024-12-31) — Net Business Purchase And Sale: 0.00
FGNXP cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 0.00
FGNXP cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 0.00
FGNXP income_statement (annual, 2024-12-31) — Net Income: -1155000.00
FGNXP income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -2565000.00
FGNXP income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -24277000.00
FGNXP income_statement (annual, 2024-12-31) — Net Income Discontinuous Operations: 22962000.00
FGNXP income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -1155000.00
FGNXP income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -24117000.00
FGNXP cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -24277000.00
FGNXP income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -1315000.00
FGNXP income_statement (annual, 2024-12-31) — Net Interest Income: -303000.00
FGNXP cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 5021000.00
FGNXP cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -5425000.00
FGNXP cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -4822000.00
FGNXP cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: -79000.00
FGNXP income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -303000.00
FGNXP cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -21000.00
FGNXP cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: -1000.00
FGNXP cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 203000.00
FGNXP cash_flow (quarterly, 2024-12-31) — Net Other Investing Changes: 153000.00
FGNXP balance_sheet (annual, 2024-12-31) — Net PPE: 2404000.00
FGNXP cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: 6161000.00
FGNXP cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: 0.00
FGNXP cash_flow (annual, 2024-12-31) — Net Preferred Stock Issuance: 0.00
FGNXP cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: -603000.00
FGNXP balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 74197000.00
FGNXP balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 2412000.00
FGNXP balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 857000.00
FGNXP balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Revenue: 857000.00
FGNXP balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 2412000.00
FGNXP income_statement (annual, 2024-12-31) — Normalized EBITDA: -24501000.00
FGNXP income_statement (annual, 2024-12-31) — Normalized Income: -24956628.00
FGNXP cash_flow (annual, 2024-12-31) — Operating Cash Flow: -4239000.00
FGNXP cash_flow (annual, 2024-12-31) — Operating Gains Losses: 15446000.00
FGNXP income_statement (annual, 2024-12-31) — Operating Income: -10234000.00
FGNXP income_statement (annual, 2024-12-31) — Operating Revenue: 779000.00
FGNXP balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 253580.00
FGNXP balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 2068000.00
FGNXP balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 29722000.00
FGNXP balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 29722000.00
FGNXP balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 1108000.00
FGNXP income_statement (annual, 2024-12-31) — Other Gand A: 9395000.00
FGNXP income_statement (annual, 2024-12-31) — Other Income Expense: -13832000.00
FGNXP cash_flow (annual, 2024-12-31) — Other Non Cash Items: -2246000.00
FGNXP cash_flow (quarterly, 2024-12-31) — Other Non Cash Items: -418000.00
FGNXP balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 606000.00
FGNXP balance_sheet (quarterly, 2024-12-31) — Other Non Current Assets: 606000.00
FGNXP balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 228000.00
FGNXP balance_sheet (quarterly, 2024-12-31) — Other Non Current Liabilities: 228000.00
FGNXP income_statement (annual, 2024-12-31) — Other Operating Expenses: 15530000.00
FGNXP income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 3067000.00
FGNXP balance_sheet (annual, 2024-12-31) — Other Properties: 1306000.00
FGNXP balance_sheet (quarterly, 2024-12-31) — Other Properties: 1306000.00
FGNXP balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 5763000.00
FGNXP balance_sheet (quarterly, 2024-12-31) — Other Short Term Investments: 5763000.00
FGNXP income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
FGNXP balance_sheet (annual, 2024-12-31) — Payables: 842000.00
FGNXP balance_sheet (quarterly, 2024-12-31) — Payables: 842000.00
FGNXP balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 842000.00
FGNXP balance_sheet (annual, 2024-12-31) — Preferred Shares Number: 894580.00
FGNXP balance_sheet (quarterly, 2024-12-31) — Preferred Shares Number: 894580.00
FGNXP balance_sheet (annual, 2024-12-31) — Preferred Stock: 22365000.00
FGNXP cash_flow (annual, 2024-12-31) — Preferred Stock Dividend Paid: -1410000.00
FGNXP income_statement (annual, 2024-12-31) — Preferred Stock Dividends: 1410000.00
FGNXP balance_sheet (annual, 2024-12-31) — Preferred Stock Equity: 22365000.00
FGNXP cash_flow (annual, 2024-12-31) — Preferred Stock Payments: 0.00
FGNXP income_statement (annual, 2024-12-31) — Pretax Income: -24369000.00
FGNXP balance_sheet (annual, 2024-12-31) — Properties: 0.00
FGNXP balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
FGNXP cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 69000.00
FGNXP cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
FGNXP cash_flow (annual, 2024-12-31) — Purchase Of Investment: 0.00
FGNXP balance_sheet (annual, 2024-12-31) — Raw Materials: 0.00
FGNXP balance_sheet (quarterly, 2024-12-31) — Raw Materials: 0.00
FGNXP balance_sheet (annual, 2024-12-31) — Receivables: 3384000.00
FGNXP balance_sheet (quarterly, 2024-12-31) — Receivables: 3384000.00
FGNXP income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 25493000.00
FGNXP income_statement (annual, 2024-12-31) — Reconciled Depreciation: 408000.00
FGNXP cash_flow (annual, 2024-12-31) — Repayment Of Debt: -5522000.00
FGNXP cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: 0.00
FGNXP income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: -2320000.00
FGNXP income_statement (quarterly, 2024-12-31) — Restructuring And Mergern Acquisition: -472000.00
FGNXP balance_sheet (annual, 2024-12-31) — Retained Earnings: -229000.00
FGNXP income_statement (annual, 2024-12-31) — Salaries And Wages: 1618000.00
FGNXP cash_flow (annual, 2024-12-31) — Sale Of Business: 1903000.00
FGNXP cash_flow (quarterly, 2024-12-31) — Sale Of Business: 0.00
FGNXP cash_flow (annual, 2024-12-31) — Sale Of Investment: 5021000.00
FGNXP cash_flow (annual, 2024-12-31) — Sale Of PPE: 6161000.00
FGNXP cash_flow (quarterly, 2024-12-31) — Sale Of PPE: 0.00
FGNXP income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 1277000.00
FGNXP income_statement (quarterly, 2024-12-31) — Selling And Marketing Expense: 305000.00
FGNXP income_statement (annual, 2024-12-31) — Selling General And Administration: 11013000.00
FGNXP balance_sheet (annual, 2024-12-31) — Share Issued: 253580.00
FGNXP cash_flow (annual, 2024-12-31) — Short Term Debt Payments: -603000.00
FGNXP income_statement (annual, 2024-12-31) — Special Income Charges: 845000.00
FGNXP cash_flow (annual, 2024-12-31) — Stock Based Compensation: 1619000.00
FGNXP balance_sheet (annual, 2024-12-31) — Stockholders Equity: 74197000.00
FGNXP balance_sheet (annual, 2024-12-31) — Tangible Book Value: 51832000.00
FGNXP income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 3372.00
FGNXP income_statement (annual, 2024-12-31) — Tax Provision: -92000.00
FGNXP income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
FGNXP balance_sheet (annual, 2024-12-31) — Total Assets: 109469000.00
FGNXP balance_sheet (annual, 2024-12-31) — Total Capitalization: 74197000.00
FGNXP balance_sheet (annual, 2024-12-31) — Total Debt: 2068000.00
FGNXP balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 74197000.00
FGNXP income_statement (annual, 2024-12-31) — Total Expenses: 11013000.00
FGNXP balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 35272000.00
FGNXP balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 57320000.00
FGNXP balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 57320000.00
FGNXP balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 2640000.00
FGNXP balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 2640000.00
FGNXP income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -11709000.00
FGNXP income_statement (annual, 2024-12-31) — Total Unusual Items: 843000.00
FGNXP income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 843000.00
FGNXP balance_sheet (annual, 2024-12-31) — Treasury Stock: 0.00
FGNXP balance_sheet (quarterly, 2024-12-31) — Treasury Stock: 0.00
FGNXP cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 0.00
FGNXP balance_sheet (annual, 2024-12-31) — Work In Process: 0.00
FGNXP balance_sheet (quarterly, 2024-12-31) — Work In Process: 0.00
FGNXP balance_sheet (annual, 2024-12-31) — Working Capital: 19517000.00
FGNXP balance_sheet (quarterly, 2024-12-31) — Working Capital: 19517000.00
FGNXP income_statement (annual, 2024-12-31) — Write Off: 1475000.00
FGNXP income_statement (quarterly, 2024-12-31) — Write Off: 0.00
FGNXP income_statement (quarterly, 2025-03-31) — +Operating Expense: 2512000.00
FGNXP income_statement (quarterly, 2025-03-31) — +Total Revenue: 128000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 5725000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 3675000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -1631000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 51099000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 0.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Assets Held For Sale Current: 31961000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 6562000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 3250000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -14000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -14000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 1244000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Capital Stock: 22394000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 5669000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 10389000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -447000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -578000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 1533000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -2374000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Cash From Discontinued Financing Activities: -142000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Cash From Discontinued Investing Activities: -14000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Cash From Discontinued Operating Activities: -549000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Change In Inventory: -638000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 124000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -51000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 83000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -521000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Change In Receivables: -18000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -314000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -18000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Changes In Cash: -2124000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Common Stock: 29000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 41788000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Common Stock Payments: 0.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 14000.00
FGNXP income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 5717000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Current Assets: 48110000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Current Debt: 1940000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 1940000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 1314000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 1314000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Current Deferred Taxes Liabilities: 2270000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 32268000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -151000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Deferred Tax: -151000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 78000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 78000.00
FGNXP income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -10202000.00
FGNXP income_statement (quarterly, 2025-03-31) — EBIT: -2384000.00
FGNXP income_statement (quarterly, 2025-03-31) — EBITDA: -2306000.00
FGNXP income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest: -6419000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Earnings Losses From Equity Investments: 7237000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -1000.00
FGNXP cash_flow (quarterly, 2025-03-31) — End Cash Position: 4437000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -720000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Finished Goods: 2082000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -2923000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 4000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of Business: -770000.00
FGNXP income_statement (quarterly, 2025-03-31) — Gain On Sale Of Ppe: 0.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 1091000.00
FGNXP income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 2512000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Gross PPE: 5496000.00
FGNXP income_statement (quarterly, 2025-03-31) — Gross Profit: -5325000.00
FGNXP income_statement (quarterly, 2025-03-31) — Interest Expense: 33000.00
FGNXP income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 33000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Inventory: 2085000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Invested Capital: 43962000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 1519000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 47300000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 45000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Line Of Credit: 0.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 1244000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 234000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 1478000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -142000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 47300000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 1003000.00
FGNXP income_statement (quarterly, 2025-03-31) — Minority Interests: 0.00
FGNXP cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: 0.00
FGNXP cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
FGNXP income_statement (quarterly, 2025-03-31) — Net Income: -9755000.00
FGNXP income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -10202000.00
FGNXP income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -8629000.00
FGNXP income_statement (quarterly, 2025-03-31) — Net Income Discontinuous Operations: -1126000.00
FGNXP income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -9755000.00
FGNXP income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -8629000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -8629000.00
FGNXP income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -9755000.00
FGNXP income_statement (quarterly, 2025-03-31) — Net Interest Income: -4000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 1533000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -131000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -142000.00
FGNXP income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -4000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Net PPE: 3865000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Net Preferred Stock Issuance: 0.00
FGNXP cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: -131000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 64153000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 2270000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 2270000.00
FGNXP income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -2306000.00
FGNXP income_statement (quarterly, 2025-03-31) — Normalized Income: -8629000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -2923000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 6467000.00
FGNXP income_statement (quarterly, 2025-03-31) — Operating Income: -2384000.00
FGNXP income_statement (quarterly, 2025-03-31) — Operating Revenue: 128000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 254323.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 1940000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 23289000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 1091000.00
FGNXP income_statement (quarterly, 2025-03-31) — Other Gand A: 2337000.00
FGNXP income_statement (quarterly, 2025-03-31) — Other Income Expense: -6309000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 47000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 1034000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 140000.00
FGNXP income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 110000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Other Properties: 1184000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 4720000.00
FGNXP income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Payables: 5725000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 5725000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Preferred Shares Number: 894580.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 22365000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Preferred Stock Dividend Paid: -447000.00
FGNXP income_statement (quarterly, 2025-03-31) — Preferred Stock Dividends: 447000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Preferred Stock Equity: 22365000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Preferred Stock Payments: 0.00
FGNXP income_statement (quarterly, 2025-03-31) — Pretax Income: -8697000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
FGNXP cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: 9000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -277000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Raw Materials: 0.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Receivables: 3675000.00
FGNXP income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 5717000.00
FGNXP income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 78000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -131000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: 0.00
FGNXP income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: -18000.00
FGNXP balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -10431000.00
FGNXP income_statement (quarterly, 2025-03-31) — Salaries And Wages: 175000.00
FGNXP cash_flow (quarterly, 2025-03-31) — Sale Of Business: 0.00